Search results
AstraZeneca Imfinzi plus chemotherapy gets US nod for certain type of endometrial cancer
Reuters· 6 days ago, opens new tab said its blockbuster cancer drug Imfinzi combined with chemotherapy has been...
Pharma Stock Roundup: FDA Nod to MRK's New Jab & Expanded Use of ABBV & AZN Drugs
Zacks via Yahoo Finance· 1 day agoFDA approves Merck's (MRK) 21-valent pneumococcal conjugate vaccine, Capvaxive and the expanded use...
AstraZeneca (LON:AZN) Given Hold Rating at Deutsche Bank Aktiengesellschaft
ETF DAILY NEWS· 4 days agoDeutsche Bank Aktiengesellschaft reiterated their hold rating on shares of AstraZeneca (LON:AZN – Free Report) in a research report sent to investors on Tuesday, MarketBeat.com ...
Data Science Hiring Process at AstraZeneca – AIM
Analytics India Magazine· 5 days agoWith over 45 years of presence in India, British-Swedish pharmaceutical and biotechnology giant AstraZeneca has data science and AI capabilities deeply ingrained across its ...
AstraZeneca’s lung cancer drug approved by US FDA for combination chemotherapy treatment | Invezz
Invezz· 5 days agoAstraZeneca, the largest pharmaceutical group in Britain, announced that the U.S. Food and Drug...
Astrazeneca (AZN) Stock Sinks As Market Gains: Here's Why
Zacks via Yahoo Finance· 5 days agoAstrazeneca (AZN) closed at $79.31 in the latest trading session, marking a -0.35% move from the...
AstraZeneca's breast cancer drug combination fails in late-stage trial
Reuters· 5 days ago, opens new tab said on Tuesday its breast cancer drug, Truqap, in combination with chemotherapy...
AstraZeneca's (AZN) Truqap Gets EU Nod for Breast Cancer
Zacks via Yahoo Finance· 2 days agoThe European Commission approves AstraZeneca's (AZN) Truqap in combination with Faslodex for...
Gateway - Quartz
Quartz· 5 days agoCambridge, U.K.-based pharmacuetical giant AstraZeneca announced an ambitious sales goal for the end of this decade, just as it pulls it COVID-19 vaccines off the shelves.
AstraZeneca’s Truqap flops in Phase III triple negative breast cancer trial
Clinical Trials Arena via Yahoo Finance· 3 days agoAstraZeneca has been dealt a blow after its flagship breast cancer drug Truqap (capivasertib) did...
